NewAmsterdam Pharma

NAMSNasdaq Netherlands Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.788 B

$23.32 +3.28%

Close of 22 Sept 2026

Revenue

$22.5M

#2955 by revenue

Earnings

-$203.0M

Loss-making

Shares outstanding

119,537,169

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

NewAmsterdam Pharma lists more than one class of stock. Company figures above cover all classes combined.

NAMSW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#80Vicore Pharma Holding ABVCRE$2.86B
#81PrecigenPGEN$2.82B
#82NewAmsterdam PharmaNAMS$2.79B
#83Nurix TherapeuticsNRIX$2.66B
#84Structure TherapeuticsGPCR$2.63B

What if NewAmsterdam Pharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$252,925.26

Per share 10,846× higher

Bitcoin $1.74T

$14,569.99

Per share 625× higher

Nvidia $5.52T

$46,142.69

Per share 1,979× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for NewAmsterdam Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.